HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liyanage P Perera Selected Research

Influenza in Birds (Avian Flu)

3/2009Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liyanage P Perera Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 04/2008
7Vaccinia
04/2014 - 03/2003
5Tuberculosis (Tuberculoses)
01/2011 - 03/2009
4Infections
09/2013 - 04/2008
4Inflammation (Inflammations)
04/2013 - 09/2009
4Smallpox (Variola)
10/2010 - 01/2007
3Human Influenza (Influenza)
01/2022 - 04/2014
3Celiac Disease (Celiac Sprue)
01/2020 - 12/2011
3Pulmonary Tuberculosis
01/2011 - 07/2009
2Malaria
01/2015 - 01/2011
1Squamous Cell Carcinoma of Head and Neck
02/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020
1Ischemia
01/2019
1Hemorrhage
01/2019
1Papilledema
01/2019
1Pneumonia (Pneumonitis)
01/2019
1Uveitis
01/2019
1Autoimmune Lymphoproliferative Syndrome
10/2015
1Lymphadenopathy
10/2015
1Rheumatoid Arthritis
10/2015
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Melanoma (Melanoma, Malignant)
01/2015
1Inhalation anthrax
09/2013
1Enteropathy-Associated T-Cell Lymphoma
04/2013
1Capillary Leak Syndrome
05/2011
1Coinfection
01/2011
1Anthrax
10/2010
1Mpox (monkeypox)
10/2010
1Atrophy
09/2009
1Meningeal Tuberculosis (Tuberculous Meningitis)
03/2009
1Miliary Tuberculosis
03/2009
1Influenza in Birds (Avian Flu)
03/2009

Drug/Important Bio-Agent (IBA)

17Interleukin-15 (Interleukin 15)IBA
01/2020 - 03/2003
15VaccinesIBA
01/2018 - 03/2003
9CytokinesIBA
01/2018 - 03/2009
5AntigensIBA
09/2013 - 07/2009
3Proteins (Proteins, Gene)FDA Link
01/2015 - 07/2009
3Glutens (Glutelin)IBA
04/2013 - 09/2009
3Interleukin-2 (IL2)IBA
05/2011 - 03/2003
2Janus Kinase InhibitorsIBA
10/2015 - 04/2013
2tofacitinibIBA
10/2015 - 04/2013
2Influenza Vaccines (Influenza Vaccine)FDA Link
04/2014 - 03/2009
2Tuberculosis VaccinesIBA
01/2011 - 05/2010
2Smallpox Vaccine (Vaccine, Smallpox)FDA Link
10/2010 - 10/2010
2A-Form DNA (A-DNA)IBA
12/2009 - 07/2009
1Hemagglutinins (Hemagglutinin)IBA
01/2022
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2022
1Alemtuzumab (Campath)FDA Link
01/2021
1obinutuzumabIBA
01/2021
1avelumabIBA
01/2021
1mogamulizumabIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
02/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1Chemokine ReceptorsIBA
09/2017
1Chimeric Antigen ReceptorsIBA
09/2017
1Malaria VaccinesIBA
01/2015
1AntibodiesIBA
04/2014
1Anthrax Vaccines (Vaccines, Anthrax)IBA
09/2013
1HLA-DQ8 antigenIBA
04/2013
1Therapeutic UsesIBA
03/2012
1ElementsIBA
12/2011
1Mycobacterium tuberculosis antigensIBA
05/2010
1bis(p-chlorophenyl)acetic acid (DDA)IBA
12/2009
1BCG VaccineFDA Link
03/2009
1DryVax vaccineIBA
01/2007

Therapy/Procedure

2Therapeutics
10/2015 - 05/2011
1Immunomodulation
01/2019
1Intravenous Infusions
01/2019
1Immunotherapy
01/2015